SC 13G | 2024-03-22 | Deep Track Capital, LP | Olema Pharmaceuticals, Inc. | 3,040,248 | 5.4% | EDGAR |
SC 13G/A | 2024-02-14 | Cormorant Asset Management, LP | Olema Pharmaceuticals, Inc. | 2,181,800 | - | EDGAR |
SC 13G/A | 2024-02-14 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | Paradigm Biocapital Advisors LP | Olema Pharmaceuticals, Inc. | 7,903,600 | 14.3% | EDGAR |
SC 13G/A | 2024-02-12 | JANUS HENDERSON GROUP PLC | Olema Pharmaceuticals, Inc. | 700,100 | 1.3% | EDGAR |
SC 13G | 2024-01-29 | BlackRock Inc. | Olema Pharmaceuticals, Inc. | 3,263,907 | 6.0% | EDGAR |
SC 13D/A | 2023-11-28 | Logos Global Management LP | Olema Pharmaceuticals, Inc. | 4,252,005 | 7.8% | EDGAR |
SC 13D/A | 2023-09-14 | BIOTECHNOLOGY VALUE FUND L P | Olema Pharmaceuticals, Inc. | 4,688,954 | 8.6% | EDGAR |
SC 13G/A | 2023-09-13 | Paradigm Biocapital Advisors LP | Olema Pharmaceuticals, Inc. | 7,803,600 | 14.3% | EDGAR |
SC 13G | 2023-04-10 | Paradigm Biocapital Advisors LP | Olema Pharmaceuticals, Inc. | 2,515,111 | 6.2% | EDGAR |
SC 13G/A | 2023-03-22 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 2,025,234 | 5.0% | EDGAR |
SC 13G/A | 2023-02-14 | Cormorant Asset Management, LP | Olema Pharmaceuticals, Inc. | 1,582,000 | - | EDGAR |
SC 13G/A | 2023-02-14 | Fairmount Funds Management LLC | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-10 | JANUS HENDERSON GROUP PLC | Olema Pharmaceuticals, Inc. | 3,057,306 | 7.6% | EDGAR |
SC 13G | 2023-02-10 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 40,423,832 | 5.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Olema Pharmaceuticals, Inc. | 1,475,350 | 3.6% | EDGAR |
SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-11-14 | RA CAPITAL MANAGEMENT, L.P. | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2022-07-08 | BlackRock Inc. | Olema Pharmaceuticals, Inc. | 1,305,504 | 3.2% | EDGAR |
SC 13G/A | 2022-05-16 | RA CAPITAL MANAGEMENT, L.P. | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |